Skip to main content

Advertisement

SpringerLink
Log in

Interaction between gender and uric acid on hemoglobin A1c in community-dwelling persons

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Introduction

Higher glycated hemoglobin (Hb) (HbA1c) is significantly associated with an increased risk of cardiovascular disease (CVD). Serum uric acid (SUA) levels are associated with glucose intolerance and type 2 diabetes. Whether gender-specific differences regarding the relationship between SUA levels and HbA1c exist is unknown.

Aim

We recruited 1636 (men, 696 aged of 70 ± 10 years; women, 940 aged of 70 ± 9 years) participants and enrolled in the study during their annual health examination from a single community. We investigated the association between SUA levels and HbA1c within each gender.

Results

Multiple linear regression analysis showed that in men, SUA (β = −0.091, p = 0.014) with prevalence of antidiabetic medication (β = 0.428, p < 0.001) and eGFR (β = 0.112, p = 0.016) were significantly and negatively associated with HbA1c, and in women, SUA (β = 0.101, p = 0.002) with prevalence of antidiabetic medication (β = 0.458, p < 0.001) were significantly and positively associated with HbA1c. Moreover, the interaction between gender and SUA (β = 0.445, p < 0.001) as well as gender (β = −0.465, p < 0.001), prevalence of antidiabetic medication (β = 0.444, p < 0.001), eGFRCKDEPI (β = 0.074, p = 0.014), and SUA (β = −0.356, p < 0.001) was a significant and independent determinant of HbA1c. A significant interactive effect of gender and SUA on determinants of HbA1c was noted in patients not on antidiabetic medications, regardless of age, HbA1c, and renal function.

Conclusions

The interaction between gender and SUA was associated with HbA1c independent of other metabolic factors in community-dwelling persons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bash LD, Selvin E, Steffes M, Coresh J, Astor BC (2008) Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: atherosclerosis risk in communities (ARIC) study. Arch Intern Med 168:2440–2447

    Article  PubMed  PubMed Central  Google Scholar 

  2. Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH (2009) A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes 58:2649–2655

    Article  PubMed  PubMed Central  Google Scholar 

  3. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH (2004) Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421–431

    Article  CAS  PubMed  Google Scholar 

  4. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141:413–420

    Article  CAS  PubMed  Google Scholar 

  5. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362:800–811

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hernandez D, Espejo-Gil A, Bernal-Lopez MR, Mancera-Romero J, Baca-Osorio AJ, Tinahones FJ, Armas-Padron AM, Ruiz-Esteban P, Torres A, Gomez-Huelgas R (2016) Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population. BMC Nephrol 14:151

    Article  Google Scholar 

  7. Rhee JJ, Zheng Y, Montez-Rath ME, Chang TI, Winkelmayer WC (2017) Associations of glycemic control with cardiovascular outcomes among US hemodialysis patients with diabetes mellitus. J Am Heart Assoc 6:e005581

    Article  PubMed  PubMed Central  Google Scholar 

  8. Qiu Q, Gong Y, Liu X, Dou L, Wang Y, Wang B, Liang J (2015) Serum uric acid and impaired glucose tolerance: the cardiometabolic risk in chinese (CRC) study. Cell Biochem Biophys 73:155–162

    Article  CAS  PubMed  Google Scholar 

  9. Lin KC, Tsai ST, Lin HY, Chou P (2004) Different progressions of hyperglycemia and diabetes among hyperuricemic men and women in the kinmen study. J Rheumatol 31:1159–1165

    PubMed  Google Scholar 

  10. Sluijs I, Beulens JWJ, der Van ADL, Spijkerman AMW, Schulze MB, Van Der Schouw YT (2013) Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. J Nutr 143:80–85

    Article  CAS  PubMed  Google Scholar 

  11. Ito H, Abe M, Mifune M, Oshikiri K, Antoku S, Takeuchi Y, Togane M (2011) Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. PLoS One 6:e27817

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Juraschek SP, Tunstall-Pedoe H, Woodward M (2014) Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study. Atherosclerosis 233:623–629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, Saito A, Sone H (2009) Association between serum uric acid and development of type 2 diabetes. Diabetes Care 32:1737–1742

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA (2010) Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 62:170–180

    Google Scholar 

  15. Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G (2015) Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens 33:1729–1741

    Article  CAS  PubMed  Google Scholar 

  16. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K (2001) Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens 19:1209–1215

    Article  CAS  PubMed  Google Scholar 

  17. Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7–13

    Article  CAS  PubMed  Google Scholar 

  18. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD (2000) Serum uric acid and risk of coronary heart disease: atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 10:136–143

    Article  CAS  PubMed  Google Scholar 

  19. Kawamoto R, Tabara Y, Kohara K, Kusunoki T, Abe M, Miki T (2013) Serum uric acid is more strongly associated with impaired fasting glucose in women than in men from a community-dwelling population. PLoS One 8:e65886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kawamoto R, Tomita H, Oka Y, Ohtsuka N (2006) Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 45:605–614

    Article  PubMed  Google Scholar 

  21. Meisinger C, Döring A, Stöckl D, Thorand B, Kowall B, Rathmann W (2012) Uric acid is more strongly associated with impaired glucose regulation in women than in men from the general population: the KORA F4-study. PLoS One 7:e37180

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Kawamoto R, Ninomiya D, Kasai Y, Kusunoki T, Ohtsuka N, Kumagi T, Abe M (2016) Serum uric acid is positively associated with handgrip strength among japanese community-dwelling elderly women. PLoS One 11:e0151044

    Article  PubMed  PubMed Central  Google Scholar 

  23. Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S (2010) Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 56:32–38

    Article  PubMed  Google Scholar 

  24. Kawamoto R, Tabara Y, Kohara K, Kusunoki T, Abe M, Miki T (2013) Synergistic influence of age and serum uric acid on blood pressure among community-dwelling Japanese women. Hypertens Res 36:634–638

    Article  CAS  PubMed  Google Scholar 

  25. Choi HK, Ford ES (2008) Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels–the Third National Health and Nutrition Examination Survey. Rheumatology (Oxford) 47:713–717

    Article  CAS  Google Scholar 

  26. Wei F, Chang B, Yang X, Wang Y, Chen L, Li WD (2016) Serum uric acid levels were dynamically coupled with hemoglobin A1c in the development of type 2 diabetes. Sci Rep 6:28549

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT, Hu FB (2008) Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem 54:310–316

    Article  CAS  PubMed  Google Scholar 

  28. Gill A, Kukreja S, Malhotra N, Chhabra N (2013) Correlation of the serum insulin and the serum uric acid levels with the glycated haemoglobin levels in the patients of type 2 diabetes mellitus. J Clin Diagn Res 7:1295–1297

    PubMed  PubMed Central  Google Scholar 

  29. Cui Y, Bu H, Ma X, Zhao S, Li X, Lu S (2016) The relation between serum uric acid and HbA1c is dependent upon hyperinsulinemia in patients with newly diagnosed type 2 diabetes mellitus. J Diabetes Res 2016:7184123

    Article  PubMed  PubMed Central  Google Scholar 

  30. Gordon T, Kannel WB (1983) Drinking and its relation to smoking, BP, blood lipids, and uric acid. The Framingham study. Arch Intern Med 143:1366–1374

    Article  CAS  PubMed  Google Scholar 

  31. Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J (1998) Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med 158:741–751

    Article  CAS  PubMed  Google Scholar 

  32. Nicholls A, Snaith ML, Scott JT (1973) Effect of oestrogen therapy on plasma and urinary levels of uric acid. BMJ 1:449–451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Berry CE, Hare JM (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555:589–606

    Article  CAS  PubMed  Google Scholar 

  34. Tabara Y, Kohara K, Kawamoto R, Hiura Y, Nishimura K, Morisaki T, Kokubo Y, Okamura T, Tomoike H, Iwai N, Miki T (2010) Association of four genetic loci with uric acid levels and reduced renal function: the J-SHIPP Suita study. Am J Nephrol 32:279–286

    Article  CAS  PubMed  Google Scholar 

  35. Chiou WK, Wang MH, Huang DH, Chiu HT, Lee YJ, Lin JD (2010) The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese. J Epidemiol 20:219–224

    Article  PubMed  PubMed Central  Google Scholar 

  36. Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G (2008) The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 392:1–7

    Article  CAS  PubMed  Google Scholar 

  37. Pasalic D, Marinkovic N, Feher-Turkovic L (2012) Uric acid as one of the important factors in multifactorial disorders–facts and controversies. Biochem Med (Zagreb) 22:63–75

    Article  CAS  Google Scholar 

  38. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos CH, Cicoira M, Shamim W, Kemp M, Segal R, Osterziel KJ, Leyva F, Hetzer R, Ponikowski P, Coats AJ (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107:1991–1997

    Article  PubMed  Google Scholar 

  39. Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson RJ, Henderson GN (2008) Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids 27:967–978

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Zhi L, Yuzhang Z, Tianliang H, Hisatome I, Yamamoto T, Jidong C (2016) High uric acid induces insulin resistance in cardiomyocytes in vitro and in vivo. PLoS One 11:e0147737

    Article  PubMed  PubMed Central  Google Scholar 

  41. Zhang JX, Zhang YP, Wu QN, Chen B (2015) Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes. Endocrine 48:135–142

    Article  CAS  PubMed  Google Scholar 

  42. Li Q, Yang Z, Lu B, Wen J, Ye Z, Chen L, He M, Tao X, Zhang W, Huang Y, Zhang Z, Qu S, Hu R (2011) Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cariovasc Diabetol 10:72

    Article  CAS  Google Scholar 

  43. Han Nan H, Dong Y, Gao W, Tuomilehto J, Qiao Q (2007) Diabetes associated with a low serum uric acid level in a general Chinese population. Diabetes Res Clin Pract 76:68–74

    Article  Google Scholar 

  44. Nan Hairong, Pang Zengchang, Wang Shaojie, Gao Weiguo, Zhang Lei, Ren Jie, Ning Feng, Tuomilehto J, Qiao Qing (2010) Serum uric acid, plasma glucose and diabetes. Diab Vasc Dis Res 7:40–46

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by a Grant-in-Aid for Scientific Research (C) (2015-2017). No additional external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

  1. Department of Community Medicine, Ehime University Graduate School of Medicine, Tōon, Ehime, 791-0295, Japan

    R. Kawamoto, D. Ninomiya, K. Senzaki & T. Kumagi

  2. Department of Internal Medicine, Seiyo Municipal Nomura Hospital, 9-53 Nomura, Nomura-cho, Seiyo, Ehime, 797-1212, Japan

    R. Kawamoto, D. Ninomiya, Y. Kasai, T. Kusunoki & N. Ohtsuka

Authors
  1. R. Kawamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Ninomiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y. Kasai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Senzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Kusunoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Ohtsuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Kumagi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Kawamoto.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interests.

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies conducted (IRB Approval Number: 1402009).

Informed consent

Informed consent was obtained from all subjects participating in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawamoto, R., Ninomiya, D., Kasai, Y. et al. Interaction between gender and uric acid on hemoglobin A1c in community-dwelling persons. J Endocrinol Invest 41, 421–429 (2018). https://doi.org/10.1007/s40618-017-0760-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-017-0760-5

Keywords

Search

Navigation